This inventor holds 1 USPTO granted patent. Top assignee: The University of British Columbia. Active years: 2010.
Company Filing History:
Years Active: 2010
Title: Grant Mauk: Innovator in IDO Inhibitors
Introduction
Grant Mauk is a notable inventor based in Vancouver, Canada. He has made significant contributions to the field of pharmaceuticals, particularly in the development of indoleamine 2,3-dioxygenase (IDO) inhibitors. His work focuses on addressing various medical conditions that arise from the pathology of the IDO-mediated tryptophan metabolic pathway.
Latest Patents
Grant Mauk holds 1 patent related to IDO inhibitors. This patent provides pharmaceutical compositions containing these inhibitors, which are crucial for treating conditions characterized by suppressed T-cell mediated immune responses. The specific diseases targeted by these inhibitors include cataracts, neurodegenerative disorders, mood disorders, cancer, and various bacterial and viral infections. The novel compounds developed in this patent include substituted naphthalene and anthracene diones, with a particular emphasis on taurine-substituted naphthaquinone structures.
Career Highlights
Grant Mauk is affiliated with the University of British Columbia, where he continues to advance his research in the field of immunology and pharmacology. His innovative work has the potential to significantly impact the treatment of various diseases linked to tryptophan metabolism.
Collaborations
Grant has collaborated with esteemed colleagues such as Eduardo Vottero and Michel Roberge, contributing to a rich environment of research and innovation.
Conclusion
Grant Mauk's contributions to the development of IDO inhibitors represent a significant advancement in pharmaceutical science. His work not only addresses critical health issues but also showcases the importance of innovation in medical research.